Timothy Day
Co- Founder & Chief Scientific Officer Particella
Dr. Timothy Day completed his PhD in neuroscience at UC Berkeley focused on adeno-associated virus directed evolution in the retina to treat inherited forms of blindness. He then went on to co-found Particella and has led the technical side of the company for the development of a proprietary oral mRNA-LNP.
Seminars
